Zobrazeno 1 - 10
of 664
pro vyhledávání: '"K COYLE"'
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 11, Iss 4, Pp 842-855 (2024)
Abstract Four sphingosine 1‐phosphate (S1P) receptor modulators (fingolimod, ozanimod, ponesimod, and siponimod) are approved by the US Food and Drug Administration for the treatment of multiple sclerosis. This review summarizes efficacy and safety
Externí odkaz:
https://doaj.org/article/3b35a014dd2647ea854c658e2d16a68d
Autor:
R de Verteuil, M Imamura, S Zhu, C Glazener, C Fraser, N Munro, J Hutchison, A Grant, D Coyle, K Coyle, L Vale
Publikováno v:
Health Technology Assessment, Vol 12, Iss 26 (2008)
Externí odkaz:
https://doaj.org/article/bb81560e13974b9ab324734000a016a2
Autor:
Mark S. Freedman, Patricia K. Coyle, Kerstin Hellwig, Barry Singer, Daniel Wynn, Bianca Weinstock-Guttman, Silva Markovic-Plese, Andrew Galazka, Fernando Dangond, Julie Korich, Anthony T. Reder
Publikováno v:
Neurology and Therapy, Vol 13, Iss 2, Pp 283-322 (2024)
Abstract Multiple sclerosis (MS) is a chronic, progressive, inflammatory disorder of the central nervous system. Relapsing–remitting MS (RRMS), the most common form of the disease, is characterized by transient neurological dysfunction with concurr
Externí odkaz:
https://doaj.org/article/8f4b63ea68774d85b40c2425f80dbef2
Publikováno v:
JMIR Research Protocols, Vol 12, p e47932 (2023)
BackgroundDespite its promise for HIV prevention, the uptake of pre-exposure prophylaxis (PrEP) has been slow, and there have been substantial inequities in PrEP access. Young men who have sex with men and transgender women of color are most in need
Externí odkaz:
https://doaj.org/article/111c039b159b4440a98b8a5ec9e89468
Autor:
Giancarlo Comi, Mark S. Freedman, José E. Meca-Lallana, Patrick Vermersch, Byoung Joon Kim, Alexander Parajeles, Keith R. Edwards, Ralf Gold, Houari Korideck, Jeffrey Chavin, Elizabeth M. Poole, Patricia K. Coyle
Publikováno v:
BMC Neurology, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background In this pooled, post hoc analysis of a phase 2 trial and the phase 3 TEMSO, TOWER, and TENERE clinical trials, long-term efficacy and safety of teriflunomide were assessed in subgroups of patients with relapsing multiple sclerosis
Externí odkaz:
https://doaj.org/article/1cd21d4c6c73407a8b8c61321663ae51
Publikováno v:
Journal of Ayurveda and Integrative Medicine, Vol 13, Iss 2, Pp 100510- (2022)
The present study examined the effects of a proprietary Ashwagandha (Withania somnifera) root and leaf extract (NooGandha® Specnova LLC, USA) supplement for improving cognitive abilities, cortisol levels, and self-reported mood, stress, food craving
Externí odkaz:
https://doaj.org/article/3884898d277b4ced873ddfc083b9be2b
Autor:
Gavin Giovannoni, Patricia K. Coyle, Patrick Vermersch, Bryan Walker, Julie Aldridge, Axel Nolting, Andrew Galazka, Caroline Lemieux, Thomas P. Leist
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Cladribine tablets (CladT) preferentially reduce B and T lymphocyte levels. As aging is associated with a decline in immune function, the effect of CladT on lymphocyte levels may differ by age. This post hoc analysis combined data from the Phase 3 CL
Externí odkaz:
https://doaj.org/article/dd0a2bfca3cd4d47a0bd4b2a7dcbf98d
Autor:
Dejan Jakimovski, Katelyn S Kavak, Karen Zakalik, Timothy Coetzee, Malcolm Gottesman, Patricia K Coyle, Robert Zivadinov, Bianca Weinstock-Guttman
Publikováno v:
Multiple Sclerosis Journal. 29:753-756
Judicious multiple sclerosis (MS) diagnosis and early start of disease modifying therapy significantly improves long-term disability outcomes in persons with MS (pwMS). Retrospective analysis based on 25-year New York State MS Consortium (NYSMSC) dat
Publikováno v:
CNS Drugs. 36:1285-1299
Autor:
Erin K Coyle, Elisabeth Fondren
Publikováno v:
Tijdschrift voor Mediageschiedenis, Vol 24, Iss 1-2, p 1 (2021)
Externí odkaz:
https://doaj.org/article/b74a350cdcc741929bc6300ba5a98739